P3 Health Partners Inc. (NASDAQ:PIII – Get Free Report) major shareholder Pacific Founders Ugp I. Chicago bought 90,000 shares of P3 Health Partners stock in a transaction that occurred on Wednesday, August 30th. The shares were acquired at an average cost of $1.83 per share, for a total transaction of $164,700.00. Following the acquisition, the insider now owns 49,305,442 shares in the company, valued at approximately $90,228,958.86. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
P3 Health Partners Trading Up 0.5 %
Shares of PIII opened at $1.98 on Friday. The stock has a market capitalization of $619.10 million, a P/E ratio of 0.00 and a beta of 1.23. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 16.13. The firm has a fifty day simple moving average of $2.32 and a two-hundred day simple moving average of $2.16. P3 Health Partners Inc. has a twelve month low of $0.70 and a twelve month high of $7.05.
P3 Health Partners (NASDAQ:PIII – Get Free Report) last announced its quarterly earnings results on Monday, August 7th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.15. P3 Health Partners had a negative net margin of 10.92% and a negative return on equity of 2,471.27%. The business had revenue of $329.09 million during the quarter, compared to analysts’ expectations of $303.30 million. On average, research analysts anticipate that P3 Health Partners Inc. will post -0.96 EPS for the current year.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the stock. BTIG Research initiated coverage on shares of P3 Health Partners in a report on Thursday. They set a “buy” rating on the stock. TD Cowen initiated coverage on shares of P3 Health Partners in a research report on Friday, June 30th. They set a “market perform” rating for the company.
View Our Latest Stock Report on P3 Health Partners
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the business. Marietta Investment Partners LLC bought a new stake in P3 Health Partners during the 1st quarter valued at about $26,000. Squarepoint Ops LLC bought a new stake in P3 Health Partners during the 4th quarter valued at about $31,000. Walleye Trading LLC bought a new stake in P3 Health Partners during the 2nd quarter valued at about $34,000. State Board of Administration of Florida Retirement System bought a new stake in P3 Health Partners during the 2nd quarter valued at about $34,000. Finally, SlateStone Wealth LLC bought a new stake in P3 Health Partners during the 2nd quarter valued at about $39,000. 23.57% of the stock is owned by hedge funds and other institutional investors.
P3 Health Partners Company Profile
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Featured Stories
Receive News & Ratings for P3 Health Partners Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for P3 Health Partners and related companies with MarketBeat.com’s FREE daily email newsletter.